Similar articles for PMID: 29771635

Year	Number of Results
1979	1
1982	1
1985	1
1988	1
1990	1
1991	1
1994	1
1995	2
1997	2
1998	2
1999	2
2000	2
2002	4
2003	1
2004	2
2005	2
2006	2
2007	4
2008	1
2009	1
2010	4
2011	6
2012	5
2013	4
2014	5
2015	5
2016	9
2017	3
2018	17
2019	16
2020	16
2021	14
2022	13
2023	7
2024	0

1

Pathogenesis-based treatments in primary Sjogren's syndrome using artificial intelligence and advanced machine learning techniques: a systematic literature review.

Foulquier N, Redou P, Le Gal C, Rouvière B, Pers JO, Saraux A. Foulquier N, et al. Hum Vaccin Immunother. 2018;14(11):2553-2558. doi: 10.1080/21645515.2018.1475872. Epub 2018 Jun 28. Hum Vaccin Immunother. 2018. PMID: 29771635 Free PMC article.

2

Can artificial intelligence replace manual search for systematic literature? Review on cutaneous manifestations in primary Sjögren's syndrome.

Orgeolet L, Foulquier N, Misery L, Redou P, Pers JO, Devauchelle-Pensec V, Saraux A. Orgeolet L, et al. Rheumatology (Oxford). 2020 Apr 1;59(4):811-819. doi: 10.1093/rheumatology/kez370. Rheumatology (Oxford). 2020. PMID: 31504928

3

New biological therapies in Sjögren's syndrome.

Nocturne G, Cornec D, Seror R, Mariette X. Nocturne G, et al. Best Pract Res Clin Rheumatol. 2015 Dec;29(6):783-93. doi: 10.1016/j.berh.2016.02.009. Epub 2016 Mar 24. Best Pract Res Clin Rheumatol. 2015. PMID: 27107513 Review.

4

Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.

Lodde BM, Baum BJ, Tak PP, Illei G. Lodde BM, et al. Ann Rheum Dis. 2006 Nov;65(11):1406-13. doi: 10.1136/ard.2006.052761. Epub 2006 Jul 31. Ann Rheum Dis. 2006. PMID: 16880196 Free PMC article. Review.

5

Targeting primary Sjögren's syndrome.

Odani T, Chiorini JA. Odani T, et al. Mod Rheumatol. 2019 Jan;29(1):70-86. doi: 10.1080/14397595.2018.1546268. Mod Rheumatol. 2019. PMID: 30424703 Review.

6

Bibliography. Current world literature. Systemic lupus erythematosus and Sjögren's syndrome.

[No authors listed] [No authors listed] Curr Opin Rheumatol. 1999 Sep;11(5):B147-68. Curr Opin Rheumatol. 1999. PMID: 10503670 No abstract available.

7

Unmasking the pathogenic role of IL-17 axis in primary Sjögren's syndrome: a new era for therapeutic targeting?

Alunno A, Carubbi F, Bartoloni E, Bistoni O, Caterbi S, Cipriani P, Giacomelli R, Gerli R. Alunno A, et al. Autoimmun Rev. 2014 Dec;13(12):1167-73. doi: 10.1016/j.autrev.2014.08.022. Epub 2014 Aug 23. Autoimmun Rev. 2014. PMID: 25183242 Review.

8

Expression of interleukin-17 in primary Sjögren's syndrome and the correlation with disease severity: A systematic review and meta-analysis.

Zhang LW, Zhou PR, Wei P, Cong X, Wu LL, Hua H. Zhang LW, et al. Scand J Immunol. 2018 Apr;87(4):e12649. doi: 10.1111/sji.12649. Scand J Immunol. 2018. PMID: 29476557 Free article. Review.

9

Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome.

Jonsson R, Haga HJ, Gordon TP. Jonsson R, et al. Scand J Rheumatol. 2000;29(6):341-8. doi: 10.1080/030097400447525. Scand J Rheumatol. 2000. PMID: 11132201 Review.

10

Biological therapies in primary Sjögren's syndrome.

Ng WF, Bowman SJ. Ng WF, et al. Expert Opin Biol Ther. 2011 Jul;11(7):921-36. doi: 10.1517/14712598.2011.574120. Epub 2011 Apr 4. Expert Opin Biol Ther. 2011. PMID: 21457124 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

144 results

Results by year